Journal
AMERICAN JOURNAL OF HUMAN GENETICS
Volume 103, Issue 4, Pages 498-508Publisher
CELL PRESS
DOI: 10.1016/j.ajhg.2018.07.016
Keywords
-
Categories
Funding
- National Institutes of Health [P41GM103533, DP1HG007811-05]
- Basser Center for BRCA (Basser BRCA1 Innovation Award)
- Pelotonia cancer training fellowship
- Brotman Baty Institute for Precision Medicine
Ask authors/readers for more resources
Loss-of-function pathogenic variants in BRCA1 confer a predisposition to breast and ovarian cancer. Genetic testing for sequence changes in BRCA1 frequently reveals a missense variant for which the impact on cancer risk and on the molecular function of BRCA1 is unknown. Functional BRCA1 is required for the homology-directed repair (HDR) of double-strand DNA breaks, a critical activity for maintaining genome integrity and tumor suppression. Here, we describe a multiplex HDR reporter assay for concurrently measuring the effects of hundreds of variants of BRCA1 for their role in DNA repair. Using this assay, we characterized the effects of 1,056 amino acid substitutions in the first 192 residues of BRCA1. Benchmarking these results against variants with known effects on DNA repair function or on cancer predisposition, we demonstrate accurate discrimination of loss-of-function versus benign missense variants. We anticipate that this assay can be used to functionally characterize BRCA1 missense variants at scale, even before the variants are observed in results from genetic testing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available